The trial found earlier interventions with Edwards’ Sapien 3 TAVR implant brought fewer heart failure-related events after two years.
Introduced at the TCT conference in San Diego, the Allia Celeo integrates its cables, allowing it to freely rotate around the patient.
The HyperVue Integrated system combines Philip’s DeepOCT+NIRS intravascular imaging technology and X-FFR physiology assessment technology.
The Amulet 360, approved in Europe in August, features a softer body and redesigned anchors compared to the previous Amplatzer Amulet.
Presented at the Transcatheter Cardiovascular Therapeutics conference in San Diego, both trials logged low complication rates ...
Flow Medical expects a first-in-human case "very soon" and an IDE submission in 2027, co-founder and CEO Jennifer Fried tells ...
Resmed pulled one of its ventilators in September, and expects the discontinuation to weigh on growth through the rest of its ...
Stryker Q3 results missed the Street, with CEO Kevin Lobo citing a tough U.S. health insurance environment for hip and knee procedures.
Available in Europe, the Liverty TIPS stent graft helps treat the veins feeding the liver by creating a new pathway for blood ...
Lambda Surgical will soon launch a first-in-human study of its new surgical guidance platform, the startup exclusively told ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results